CIK 1016169

ANTARES PHARMA, INC.

EDGAR filings

Customers

2 disclosed

Suppliers

None disclosed

Largest customer

13%

MCK · FY to 2021-12-31

Named-customer revenue

$4.6M

1 customer · 3M to 2022-03-31

Latest period

Mar 31, 2022

10-Q filed 2022-05-10

Band height is the estimated dollar value: the disclosed share × the discloser's revenue for that period (latest full year where available) or federal dollars obligated. Each side is scaled on its own; dashed outlines are named without a figure. Click a band to open its source.

Customers 2

Companies ANTARES PHARMA, INC. discloses as major customers, as a share of ANTARES PHARMA, INC. revenue. 2 active, 0 lapsed.

Company	% of ANTARES PHARMA, INC. revenue	Est. revenue	Period	Trend	Status	Source
MCK Distributor MCKESSON CORP	13%	$23.9M	FY 2021-12-31	+1.0pp	Active	10-K 2022-03-03
In addition, we derived a significant portion of our product sales revenue from wholesale distributors including McKesson, AmerisourceBergen and Cardinal Health, which each accounted for approximately 13%, 12% and 11% of total revenues in the year ended December 31, 2021, respectively. 10-K filed 2022-03-03 Period FY 2021-01-01 to 2021-12-31 (13%), FY 2020-01-01 to 2020-12-31 (12%)Accession 0001016169-22-000028 Significant customers from which we derive 10% or more of our total revenue in each or any of the years in the three-year period ended December 31, 2021 include: Teva, McKesson, AmerisourceBergen Corporation, Cardinal Health and Covis. 10-K filed 2022-03-03 Period FY 2019-01-01 to 2019-12-31 (10%)Accession 0001016169-22-000028
CAH Distributor CARDINAL HEALTH INC	11%	$4.6M	3M 2022-03-31	+1.0pp	Active	10-Q 2022-05-10
Cardinal Health 1 11 % 11 % 10-Q filed 2022-05-10 Period 3M 2022-01-01 to 2022-03-31 (11%), 3M 2021-01-01 to 2021-03-31 (11%)Accession 0001016169-22-000044 In addition, we derived a significant portion of our product sales revenue from wholesale distributors including McKesson, AmerisourceBergen and Cardinal Health, which each accounted for approximately 13%, 12% and 11% of total revenues in the year ended December 31, 2021, respectively. 10-K filed 2022-03-03 Period FY 2021-01-01 to 2021-12-31 (11%), FY 2020-01-01 to 2020-12-31 (11%)Accession 0001016169-22-000028 Cardinal Health 10 % 11 % 11 % 11 % 10-Q filed 2021-11-04 Period 3M 2021-07-01 to 2021-09-30 (10%), 3M 2020-07-01 to 2020-09-30 (11%)Accession 0001016169-21-000045 Cardinal Health 11 % 13 % 11 % 11 % 10-Q filed 2021-08-05 Period 3M 2021-04-01 to 2021-06-30, 3M 2020-04-01 to 2020-06-30Accession 0001564590-21-041726 Cardinal Health 11 % 10 % 10-Q filed 2021-05-06 Period 3M 2020-01-01 to 2020-03-31Accession 0001564590-21-025088 Significant customers from which the Company derived 10% or more of its total revenue in each or any of the years in the three-year period ended December 31, 2020 include: Teva, McKesson, AmerisourceBergen, Cardinal Health and AMAG. 10-K filed 2021-03-02 Period FY 2019-01-01 to 2019-12-31Accession 0001564590-21-010298 Cardinal Health 11 % <10% 11 % <10% 10-Q filed 2020-11-05 Period 3M 2019-07-01 to 2019-09-30Accession 0001564590-20-051289 Cardinal Health 13 % <10% 11 % <10% 10-Q filed 2020-08-06 Period 3M 2019-04-01 to 2019-06-30Accession 0001564590-20-037823 Cardinal Health 10 % <10% 10-Q filed 2020-05-05 Period 3M 2019-01-01 to 2019-03-31Accession 0001564590-20-021313 In addition, we derived a significant portion of our product sales revenue from wholesale distributors including McKesson, AmerisourceBergen and Cardinal Health, which each accounted for approximately 12%, 12% and 11% of total revenues in 2020, respectively. 10-K filed 2021-03-02 Period FY 2018-01-01 to 2018-12-31Accession 0001564590-21-010298

Alerts are coming

Get an email when ANTARES PHARMA, INC.'s disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.